Heart-kidney interaction: epidemiology of cardiorenal syndromes

Dinna N Cruz1, Sean M Bagshaw

  • 1Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Viale Rodolfi 37, 36100 Vicenza, Italy.

Insights

This study summarizes the epidemiology of cardiorenal syndrome (CRS) and its subtypes. Understanding CRS subtypes is crucial for managing heart and kidney disease burdens and improving patient outcomes.

Area of Science:

  • Cardiorenal Medicine
  • Nephrology
  • Cardiology

Background:

  • Cardiac and kidney diseases frequently coexist and present significant clinical challenges.
  • The Acute Dialysis Quality Initiative (ADQI) recently proposed a classification for cardiorenal syndrome (CRS) and its five subtypes.

Purpose of the Study:

  • To provide a comprehensive summary of the epidemiology of cardiorenal syndrome (CRS) and its distinct subtypes.
  • To highlight the importance of understanding CRS epidemiology for disease burden assessment, risk stratification, and clinical study design.

Main Methods:

  • Review and synthesis of existing epidemiological data on cardiorenal syndrome.
  • Analysis stratified by the proposed CRS subtypes to identify distinct features.

Main Results:

  • Cardiorenal syndrome encompasses complex heart-kidney interactions with significant morbidity and mortality.
  • Each of the five proposed CRS subtypes may share pathophysiologic mechanisms but possess unique clinical characteristics.

Conclusions:

  • Epidemiological knowledge of CRS subtypes is essential for evaluating disease burden, health resource utilization, and identifying research gaps.
  • Further epidemiological characterization of CRS subtypes will aid in developing targeted interventions and improving patient care.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...